Turnstone Biologics (TSBX) Stock Forecast & Price Target

$2.55

+0.04 (+1.59%)

(As of 07/26/2024 ET)

Turnstone Biologics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 4 Analyst Ratings

Based on 4 Wall Street analysts who have issued ratings for Turnstone Biologics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 2 have given a hold rating, and 2 have given a buy rating for TSBX.

Consensus Price Target

$19.00
645.10% Upside

High Forecast	$20.00
Average Forecast	$19.00
Low Forecast	$18.00

According to the 4 analysts' twelve-month price targets for Turnstone Biologics, the average price target is $19.00. The highest price target for TSBX is $20.00, while the lowest price target for TSBX is $18.00. The average price target represents a forecasted upside of 645.10% from the current price of $2.55.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	N/A
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$19.00	$19.00	$19.00	N/A
Forecasted Upside	645.10% Upside	61.98% Upside	61.98% Upside	N/A

Get Turnstone Biologics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

TSBX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TSBX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Turnstone Biologics Stock vs. The Competition

Type	Turnstone Biologics	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	645.10% Upside	3,123.46% Upside	9.18% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/15/2023	Leerink Partnrs 0 of 5 stars	D. Graybosch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
8/15/2023	SVB Securities 5 of 5 stars		Initiated Coverage	Market Perform
8/15/2023	Bank of America 4 of 5 stars		Initiated Coverage	Buy	$18.00	+53.45%
8/15/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$20.00	+70.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:25 AM ET.

TSBX Forecast - Frequently Asked Questions

What is Turnstone Biologics' forecast for 2024?: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Turnstone Biologics is $19.00, with a high forecast of $20.00 and a low forecast of $18.00.
Should I buy or sell Turnstone Biologics stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Turnstone Biologics in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TSBX shares.
Does Turnstone Biologics's stock price have much upside?: According to analysts, Turnstone Biologics's stock has a predicted upside of 61.98% based on their 12-month stock forecasts.
Do Wall Street analysts like Turnstone Biologics more than its competitors?: Analysts like Turnstone Biologics less than other "medical" companies. The consensus rating score for Turnstone Biologics is 2.50 while the average consensus rating score for "medical" companies is 2.72. Learn more on how TSBX compares to other companies.